Valproate, levocarnitine (DrugBank: Valproate, Levocarnitine)
10 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
3 | Spinal muscular atrophy | 1 |
5 | Progressive supranuclear palsy | 0 |
13 | Multiple sclerosis/Neuromyelitis optica | 0 |
53 | Sjogren syndrome | 0 |
58 | Hypertrophic cardiomyopathy | 0 |
96 | Crohn disease | 0 |
97 | Ulcerative colitis | 0 |
265 | Lipodystrophy | 0 |
298 | Hereditary pancreatitis | 0 |
316 | Carnitine cycle disorder | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01671384 (ClinicalTrials.gov) | August 2013 | 13/8/2012 | Valproate and Levocarnitine in Children With Spinal Muscular Atrophy | Randomized Placebo Controlled Trial of Valproate and Levocarnitine in Children With Spinal Muscular Atrophy Aged 2-15 Years | Spinal Muscular Atrophy | Drug: Valproate, Levocarnitine;Drug: Placebo | All India Institute of Medical Sciences, New Delhi | NULL | Recruiting | 2 Years | 15 Years | Both | 60 | Phase 3 | India |